89
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy

, , ORCID Icon, , , , , , , & ORCID Icon show all
Pages 2879-2888 | Received 13 Dec 2023, Accepted 07 Mar 2024, Published online: 19 Mar 2024

References

  • Deng T, Hasan I, Roy S., et al. Advances in mRNA nanomedicines for malignant brain tumor therapy. Smart Mater Med. 2023;4:257–265. doi:10.1016/j.smaim.2022.11.001
  • Wu W, Pu Y, Shi J. Nanomedicine-enabled chemotherapy-based synergetic cancer treatments. J Nanobiotechnol. 2022;20(1):4. doi:10.1186/s12951-021-01181-z
  • Yi Y, Yu M, Li W, et al. Vaccine-like nanomedicine for cancer immunotherapy. J Control Release. 2023;355:760–778. doi:10.1016/j.jconrel.2023.02.015
  • Zhang Y, Zhang H, Zhao F, et al. Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment. Acta Pharm Sin B. 2023;2:1.
  • Sun L, Liu H, Ye Y, et al. Smart nanoparticles for cancer therapy. Signal Transduct Target Ther. 2023;8(1):418. doi:10.1038/s41392-023-01642-x
  • Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27(4):1372. doi:10.3390/molecules27041372
  • Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541–550. doi:10.1038/s41591-018-0014-x
  • Chhabra Y, Weeraratna AT. Fibroblasts in cancer: unity in heterogeneity. Cell. 2023;186(8):1580–1609. doi:10.1016/j.cell.2023.03.016
  • Wang M, Zhao J, Zhang L, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761–773. doi:10.7150/jca.17648
  • Miao L, Newby JM, Lin CM, et al. The binding site barrier elicited by tumor-associated fibroblasts interferes disposition of nanoparticles in stroma-vessel type tumors. ACS nano. 2016;10(10):9243–9258. doi:10.1021/acsnano.6b02776
  • Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, et al. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120. doi:10.1038/s41467-020-18794-x
  • Zhang H, Yue X, Chen Z, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22(1):159. doi:10.1186/s12943-023-01860-5
  • Sahai E, Astsaturov I, Cukierman E, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174–186. doi:10.1038/s41568-019-0238-1
  • Fernández-Nogueira P, Fuster G, Gutierrez-Uzquiza Á, et al. Cancer-associated fibroblasts in breast cancer treatment response and metastasis. Cancers. 2021;13(13):3146. doi:10.3390/cancers13133146
  • Khawar IA, Kim JH, Kuh HJ. Improving drug delivery to solid tumors: priming the tumor microenvironment. J Control Release. 2015;201:78–89. doi:10.1016/j.jconrel.2014.12.018
  • Schachtschneider KM, Schwind RM, Newson J, et al. The oncopig cancer model: an innovative large animal translational oncology platform. Front Oncol. 2017;7:190. doi:10.3389/fonc.2017.00190
  • Xu M, Zhang T, Xia R, et al. Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022;21(1):208. doi:10.1186/s12943-022-01670-1
  • Nsairat H, Khater D, Sayed U, et al. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8(5):e09394. doi:10.1016/j.heliyon.2022.e09394
  • Hong C, Wang D, Liang J, et al. Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer. Theranostics. 2019;9(15):4437. doi:10.7150/thno.34953
  • Hong C, Liang J, Xia J, et al. One stone four birds: a novel liposomal delivery system multi-functionalized with ginsenoside Rh2 for tumor targeting therapy. Nanomicro Lett. 2020;12:1–18.
  • Xia J, Zhang S, Zhang R, et al. Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes. J Nanobiotechnol. 2022;20(1):414. doi:10.1186/s12951-022-01623-2
  • Zhu Y, Liang J, Gao C, et al. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy. J Control Release. 2021;330:641–657. doi:10.1016/j.jconrel.2020.12.036
  • Chen C, Xia J, Ren H, et al. Effect of the structure of ginsenosides on the in vivo fate of their liposomes. Asian J Pharm Sci. 2022;17(2):219–229. doi:10.1016/j.ajps.2021.12.002
  • Lu H, Stenzel MH. Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles. Small. 2018;14(13):e1702858. doi:10.1002/smll.201702858
  • McCarthy JB, El-Ashry D, Turley EA. Hyaluronan, cancer-associated fibroblasts and the tumor microenvironment in malignant progression. Front Cell Dev Biol. 2018;6:48. doi:10.3389/fcell.2018.00048
  • Nissen NI, Karsdal M, Willumsen N. Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology. J Exp Clin Cancer Res. 2019;38(1):1–12. doi:10.1186/s13046-019-1110-6